Dr. John Langstaff


Dr. John Langstaff completed his undergraduate work in Biology at The University of Winnipeg in 1975 and went on to receive a PhD in Microbiology.  A NATO science fellowship led to post-doctoral work at King’s College in London, England, followed by a post-doctoral fellowship at Cold Spring Harbor Laboratory in New York.

Dr. Langstaff has 14 years experience in the business of biopharmaceuticals.  He became President and CEO of Cangene Corporation in 1995 when Cangene amalgamated with Winnipeg-based Rh Pharmaceuticals Inc., where he had been Research Director, Vice-President Research and Operations, and President and CEO.

A recognized leader in the biotechnology field, Dr. Langstaff is committed to the development of Science and the healthcare industry in Canada.  As well as memberships in various industry organizations, he is the Past Chair of the national organization Bio-Net, a founder of the Healthcare Products Association of Manitoba, Co-Chair of the Science and Technology Committee for the Economic Innovation and Technology Council of Manitoba, and a Board member of 2000 Association Industries, a product-development firm specializing in electron-beam processing and operating out of Pinawa’s Whiteshell Laboratories.

In recognition of his longstanding mentorship of students at both The University of Winnipeg and the University of Manitoba, and his exceptional service to the community, Dr. Langstaff received the Fall 2000 University of Winnipeg Distinguished Alumni Award.